openPR Logo
Press release

U.S. Ketamine Clinics Market Size, Emerging Trends, Industry Leaders and Report 2023-2028

10-19-2023 07:51 AM CET | Health & Medicine

Press release from: IMARC Group

U.S. Ketamine Clinics Market Report 2023

U.S. Ketamine Clinics Market Report 2023

How Big Is the U.S. Ketamine Clinics Market?

The U.S. ketamine clinics market size reached US$ 3.24 Billion in 2022 and is expected to reach US$ 5.91 Billion by 2028, exhibiting a growth rate (CAGR) of 10.60% during 2023-2028.

What is Ketamine Clinics?

Ketamine clinics are medical facilities that specialize in the administration of ketamine, which is a powerful anesthetic and analgesic medication. These clinics are known for their use of ketamine in the treatment of various mental health conditions, such as depression, anxiety, and post-traumatic stress disorder (PTSD). At a ketamine clinic, trained medical professionals carefully administer ketamine through intravenous (IV), intramuscular (IM), or nasal spray routes, typically in low doses. The treatment is often referred to as ketamine therapy or infusion therapy, which is used off-label for mental health conditions when other treatments have proven ineffective. Moreover, ketamine clinics help individuals feel relief through ketamine therapy who have not responded to traditional antidepressants. As ketamine clinics prioritize patient safety, monitoring, and a controlled environment to minimize potential side effects and ensure a positive experience, their demand is rising in the US.

Request for a PDF sample of this report: https://www.imarcgroup.com/us-ketamine-clinics-market/requestsample

U.S. Ketamine Clinics Market Trends and Drivers:

The increasing prevalence of mental health conditions like depression, anxiety, and post-traumatic stress disorder (PTSD) is creating a substantial demand for innovative treatments in the US. Ketamine is showing rapid and often effective results in treating these conditions, driving patients and healthcare providers to explore its potential. In addition, ketamine offers hope for individuals with treatment-resistant depression, leading them to seek out specialized ketamine clinics for alternative solutions in the US. Besides this, the increasing awareness about the benefits of ketamine therapy is encouraging more patients to seek this treatment option. Word-of-mouth recommendations, testimonials, and media coverage are contributing to a higher level of public awareness in the country. Moreover, the training of medical professionals to administer ketamine therapy safely is leading to an increase in the number of clinics offering these services, improving accessibility for patients. In line with this, some insurance providers in the US are starting to cover ketamine therapy for certain conditions. This development is making the treatment more affordable and accessible to a broader patient population in the country.

Read Full Report: https://www.imarcgroup.com/us-ketamine-clinics-market

What Is Included In Market Segmentation?

The report has segmented the market into the following categories:

Breakup by Treatment:
• Depression
• Anxiety
• PTSD
• Others

Breakup by Therapy:
• On-Site Therapy
• Online Therapy

Breakup by Region:
• Northeast
• Midwest
• South
• West

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=8356&flag=C

The report provides a comprehensive analysis of the industry key players listed below:
• Better U LLC
• Field Trip Health and Wellness Ltd.
• Innerwell
• Ketamine Clinics Los Angeles
• Klarisana - Ketamine Treatment Austin
• Klarity Clinic
• Mindbloom Inc.
• Nue Life Health PBC
• NY Ketamine Infusions
• Vitalitas Denver

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Ketamine Clinics Market Size, Emerging Trends, Industry Leaders and Report 2023-2028 here

News-ID: 3255950 • Views:

More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: 5.3%
GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview Market Size in 2024: USD 266.2 Million Market Size in 2033: USD 422.9 Million Market Growth Rate 2025-2033: 5.3% According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | With a 7.50% CAGR
GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview Market Size in 2024: USD 73.31 Billion Market Size in 2033: USD 147.77 Billion Market Growth Rate 2025-2033: 7.50% According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAGR
GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview Market Size in 2024: USD 588.2 Million Market Size in 2033: USD 2,005.3 Million Market Growth Rate 2025-2033: 13.3% According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview: The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach

All 5 Releases


More Releases for Ketamine

Helloinnerwell Unveils the Transformative Benefits of Ketamine for Mental Health …
Depression and anxiety remain major barriersto fulfillment for millions around the world. Traditional antidepressants may take weeks to months to have an effect, and many experience disastrous results, no results, or side effectsthat we do not want. But a new, scientifically backed treatmentnow exists that can bring you jarred relief, potentially fast and it uses a very interesting, and run-of-the-mill drug online therapy [https://helloinnerwell.com/] of ketamine. Compared to traditional medications, ketamine provides
Breakthroughs in Mental Health: Calliope Health Ketamine Expands Access to Ketam …
In recent years, the landscape of mental health treatment has seen remarkable advancements, with innovative therapies offering new hope to those battling conditions like depression, anxiety, and PTSD. Among these breakthroughs, ketamine therapy has emerged as a powerful option, providing rapid relief for individuals who have not responded to traditional treatments. Calliope Health Ketamine is at the forefront of this movement, expanding access to ketamine therapy in Maryland, where it
Ketamine treatment Market Share, Trends, Growth, Analysis and Forecast 2023-2030
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use
Ketamine treatment Market 2023 Driving Factors Forecast Research 2029
Ketamine treatment market is anticipated to grow at a CAGR of 43.74% during the forecast period (2023-2030). The market's growth is attributed to prevalence of treatment-resistant depression. A considerable number of individuals with MDD do not respond to standard therapies, resulting in a patient group known as TRD. This population has a significant unmet medical need. Ketamine's ability to bring relief to TRD sufferers has resulted in its increased use
Ketamine Treatment Market to Witness Astonishing Growth by 2029
The global ketamine treatment market is anticipated to grow at a CAGR of 43.7% during the forecast period (2023-2030). Ketamine has been widely used in the treatment of various conditions, including major depressive disorder, treatment-resistant depression (TRD), bipolar depression, post-traumatic stress disorder, anxiety disorders, chronic pain management, and migraine or headache management. Ketamine is also been used in the form of infusion therapy and nasal spray, and has been found